Displaying results 1 - 6 / 6
results / page
What information about granted funding does the service contain?
Granted funding
Funder
Recipient
Starting year
Finnish Sleep Cohort: 10-year follow-up of initially healthy and sleep apnea patients to determine the time of onset in the past and predict the progression of the disease in the futureResearch Council of FinlandItä-Suomen yliopisto2024From optimal celiac disease diagnostics and follow-up towards better long-term healthResearch Council of FinlandTampereen yliopisto2024Bone, gut, and gonad connections in APS-1 - A prospective cohort studyResearch Council of FinlandHelsingin seudun yliopistollisen keskussairaalan erityisvastuualue2023Molecular, vesicular, and cellular mechanisms of heart transplantation – integrated multi-omics atlas to improve organ allocation and outcomeResearch Council of FinlandHelsingin yliopisto2022Student selection and competence development in the continuum of preservice and in-service teacher education (SITE)Research Council of FinlandJyväskylän yliopisto2021Progressive myoclonus epilepsy type 1 (EPM1) Better characterization of the disease progression, developing advanced clinical follow-up instruments and determination of biomarkers for future personalized treatmentResearch Council of FinlandPohjois-Savon hyvinvointialue2020
Finnish Sleep Cohort: 10-year follow-up of initially healthy and sleep apnea patients to determine the time of onset in the past and predict the progression of the disease in the future
2024
From optimal celiac disease diagnostics and follow-up towards better long-term health
2024
Bone, gut, and gonad connections in APS-1 - A prospective cohort study
2023
Molecular, vesicular, and cellular mechanisms of heart transplantation – integrated multi-omics atlas to improve organ allocation and outcome
2022
Student selection and competence development in the continuum of preservice and in-service teacher education (SITE)
2021
Progressive myoclonus epilepsy type 1 (EPM1) Better characterization of the disease progression, developing advanced clinical follow-up instruments and determination of biomarkers for future personalized treatment
2020